Neurobiology of the effect of psilocybin in relation to its potential therapeutic targets

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F16%3A43915046" target="_blank" >RIV/00023752:_____/16:43915046 - isvavai.cz</a>
Result on the web
<a href="http://www.sciencedirect.com/science/article/pii/B978012800212400073X" target="_blank" >http://www.sciencedirect.com/science/article/pii/B978012800212400073X</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/B978-0-12-800212-4.00073-X" target="_blank" >10.1016/B978-0-12-800212-4.00073-X</a>

Result language
angličtina
Original language name
Neurobiology of the effect of psilocybin in relation to its potential therapeutic targets
Original language description
This chapter focuses on the potential use of serotonergic hallucinogen psilocybin in clinical as well as experimental psychiatry, addictology, and neurology. It presents the results of recent clinical studies with psilocybin and summarizes the psychological and neurobiological aspects of its effect in specific therapeutic indications. In addition, it discusses the association between the psychotomimetic and therapeutic effects of this drug within the framework of the "entropic brain" theory.
Czech name
—
Czech description
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Book/collection name
Neuropathology of Drug Addictions and Substance Misuse - Volume 2: Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects
ISBN
978-0-12-800212-4
Number of pages of the result
12
Pages from-to
782-793
Number of pages of the book
1143
Publisher name
Elsevier
Place of publication
New York
UT code for WoS chapter
—

Similar results(10)